Mechanistic studies have shown that MiR-223 induces resistance to cisplatin and trastuzumab in GC cells by downregulating FBXW7 expression (Zhou et al., 2015; Eto et al., 2015). This evidence concerns the gene FBXW7 and gastric cancer.